Market Cap (In USD)
62.98 Million
Revenue (In USD)
-
Net Income (In USD)
-4.3 Million
Avg. Volume
195.69 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 3.03-32.44
- PE
- -
- EPS
- -
- Beta Value
- -0.602
- ISIN
- KYG7487R1002
- CUSIP
- G7487R100
- CIK
- 1829667
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Yat-Gai Au
- Employee Count
- -
- Website
- https://www.regencellbioscience.com
- Ipo Date
- 2021-07-16
- Details
- Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
More Stocks
-
METROPOLISMetropolis Healthcare Limited
METROPOLIS
-
002306
-
7247Mikuni Corporation
7247
-
2328
-
ITDCEM
-
CTD
-
LESHAINDLesha Industries Limited
LESHAIND
-
KBGCFLion Rock Resources Inc.
KBGCF